People: Koninklijke DSM NV (RDSMY.PK)

RDSMY.PK on OTC Markets Group

15.72USD
3:32pm EST
Price Change (% chg)

$0.08 (+0.51%)
Prev Close
$15.64
Open
$15.64
Day's High
$15.72
Day's Low
$15.56
Volume
29,274
Avg. Vol
49,991
52-wk High
$19.88
52-wk Low
$14.07

Search Stocks

Doboczky, Stefan 

Brief Biography

Mr. Stefan Doboczky has served as Member of the Managing Board of Koninklijke DSM NV (DSM) since May 2011. Prior to joining the Company in 1998, he worked for 6 years at ARCO Chemicals in Austria and the United Kingdom. At DSM, Mr. Doboczky started in the DSM Fine Chemicals division, where he became Business Manager. In 2002 he moved to DSM Pharma Chemicals where he was Business Director from 2003 till 2006 based in the Netherlands. In 2006, he became Vice President and Business Unit Director China for DSM Anti-Infectives based in China. Since 2009 he has been Business Group Director of DSM Anti-Infectives. Since becoming a Member of the Managing Board of Koninklijke DSM NV in May 2011 he has been responsible for DSM's global activities in Pharma, as well as all DSM's activities in Asia. He is also CEO of DSM Sinochem Pharmaceutical, a joint venture between DSM and Sinochem in the area of anti-infectives. Mr. Doboczky holds a Masters degree in Chemistry and a PhD degree in Natural and Technical Science from the University of Vienna and an MBA from IMD Business School in Lausanne, Switzerland.

Basic Compensation

Total Annual Compensation, EUR Long-Term Incentive Plans, EUR All Other, EUR Fiscal Year Total, EUR
662,175 -- 17,253 679,428

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Routs

78,185

Feike Sijbesma

1,504,120

Ewald Kist

63,538

Rolf-Dieter Schwalb

748,227

Chris Goppelsroeder

737,217

Dave Huizing

--
As Of 30 Dec 2012
Search Stocks